This site is fictional demo content. It is not real news or affiliated with any real organization. Do not treat it as fact or professional advice.

NextPaper Logo
nextpaper.ccCYBER CHRONICLE
RSS
EN中文

Full article

FULL TEXT

View this issue
Deep diveTECH

Deep Dive: Brain-Computer Interfaces Enter the Consumer Market — Neuralink vs NeuroLink

Neuralink's N2 and NeuroLink's Aura launch simultaneously, representing invasive and non-invasive BCI approaches. First user reports reveal significant differences in precision, comfort, and pricing.

January 2028 marks a pivotal moment for the consumer brain-computer interface (BCI) market. Neuralink's N2 and Shenzhen-based NeuroLink's Aura have launched almost simultaneously, representing radically different technological approaches and sparking intense debate about the future direction of BCI.

Neuralink N2 uses an invasive approach requiring a small hole drilled in the skull to implant a microelectrode array. Priced at $4,999 plus approximately $2,000 in surgical costs, its total ownership cost runs about $7,000. Its advantage lies in extremely high signal precision, capturing individual neuron firing activity with a typing speed test reaching 62 words per minute—approaching normal typing speed.

NeuroLink Aura takes a non-invasive approach, resembling a lightweight headset that captures brain signals through a high-density dry electrode array on the scalp. Aura retails for $1,299 and requires no surgery. While its typing speed reaches only 28 words per minute, it performs excellently in daily scenario controls such as switching music, adjusting lighting, and browsing the web.

Feedback from the first 500 users has highlighted core differences between the two approaches. N2 users universally praised its precision, though approximately 23% reported post-surgical discomfort including mild headaches and itching at the implant site. Aura users gave high marks for ease of use, but about 31% noted significant signal quality degradation in noisy environments.

"These two products essentially target different markets," analyzed Professor Li Ming, director of Tsinghua University's Brain Science Center. "N2 targets professional users and people with disabilities who require extreme precision, while Aura targets the broader consumer market."

Both products face data privacy concerns. Brain signals contain vast amounts of sensitive personal neural information, and no country has yet enacted dedicated brain data protection legislation. The EU initiated legislative discussions on a "Neural Data Protection Regulation" in early January.

IDC forecasts the global consumer BCI market will reach $4.7 billion in 2028, potentially exceeding $20 billion by 2032.